Koninklijke Philips NV

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: NL0000009538
EUR
22.74
-0.3 (-1.3%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.12 M

Shareholding (Mar 2024)

FII

0.00%

Held by 2 FIIs

DII

84.75%

Held by 0 DIIs

Promoter

15.25%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months

  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 6,127.67 times
  • The company has reported losses. Due to this company has reported negative ROE
2

With ROE of 1.05%, it has a Very Expensive valuation with a 2.20 Price to Book Value

3

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 22,792 Million ()

stock-summary
P/E

209.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

17.32%

stock-summary
Debt Equity

0.37

stock-summary
Return on Equity

1.51%

stock-summary
Price to Book

2.16

Revenue and Profits:
Net Sales:
4,097 Million
(Quarterly Results - Mar 2025)
Net Profit:
78 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.41%
0%
-5.41%
6 Months
11.31%
0%
11.31%
1 Year
-7.52%
0%
-7.52%
2 Years
25.4%
0%
25.4%
3 Years
83.89%
0%
83.89%
4 Years
-25.28%
0%
-25.28%
5 Years
-42.34%
0%
-42.34%

Koninklijke Philips NV for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
24.44%
EBIT Growth (5y)
298.98%
EBIT to Interest (avg)
1.97
Debt to EBITDA (avg)
6,127.67
Net Debt to Equity (avg)
0.55
Sales to Capital Employed (avg)
0.80
Tax Ratio
25.47%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
19.60%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
209
Industry P/E
Price to Book Value
2.20
EV to EBIT
46.98
EV to EBITDA
25.20
EV to Capital Employed
1.73
EV to Sales
1.65
PEG Ratio
1.64
Dividend Yield
17.27%
ROCE (Latest)
3.69%
ROE (Latest)
1.05%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is -0.99% vs -0.70% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is 107.82% vs -50.08% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,097.00",
          "val2": "4,138.00",
          "chgp": "-0.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "487.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "82.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-67.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "78.00",
          "val2": "-998.00",
          "chgp": "107.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "51.50%",
          "val2": "0.00%",
          "chgp": "5.15%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -0.81% vs 1.92% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -85.24% vs 71.94% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18,021.00",
          "val2": "18,169.00",
          "chgp": "-0.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,397.00",
          "val2": "2,082.00",
          "chgp": "15.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "288.00",
          "val2": "277.00",
          "chgp": "3.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-349.00",
          "val2": "-429.00",
          "chgp": "18.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-841.00",
          "val2": "-454.00",
          "chgp": "-85.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "68.50%",
          "val2": "43.60%",
          "chgp": "2.49%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'25 - YoYstock-summary
Mar'25
Mar'24
Change(%)
Net Sales
4,097.00
4,138.00
-0.99%
Operating Profit (PBDIT) excl Other Income
487.00
0.00
Interest
82.00
0.00
Exceptional Items
-67.00
0.00
Consolidate Net Profit
78.00
-998.00
107.82%
Operating Profit Margin (Excl OI)
51.50%
0.00%
5.15%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2025 is -0.99% vs -0.70% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2025 is 107.82% vs -50.08% in Mar 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
18,021.00
18,169.00
-0.81%
Operating Profit (PBDIT) excl Other Income
2,397.00
2,082.00
15.13%
Interest
288.00
277.00
3.97%
Exceptional Items
-349.00
-429.00
18.65%
Consolidate Net Profit
-841.00
-454.00
-85.24%
Operating Profit Margin (Excl OI)
68.50%
43.60%
2.49%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -0.81% vs 1.92% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -85.24% vs 71.94% in Dec 2023

stock-summaryCompany CV
About Koninklijke Philips NV stock-summary
stock-summary
Koninklijke Philips NV
Pharmaceuticals & Biotechnology
Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care & Health Informatics businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The HealthTech Other segment comprises such items, as innovation, emerging businesses, royalties, among others. The Legacy Items segment consists mainly of separation costs, legacy legal items, legacy pension costs, among others.
Company Coordinates stock-summary
Company Details
Breitner Center, Amstelplein 2 , AMSTERDAM None : 1096 BC
stock-summary
Tel: 31 20 597777731 31 205977222
stock-summary
Registrar Details